The impact of ageing on the health and wellbeing of people with thalidomide embryopathy: a comparison of the health impact with the general population
Article in Disability and Rehabilitation (February 2024)
The most recent citing publications are shown below. View all 4 publications that cite this research output on Dimensions.
Thalidomide interaction with inflammation in idiopathic pulmonary fibrosis
Article in Inflammopharmacology (March 2023)
Health‐related quality of life after 50 years in individuals with thalidomide embryopathy: Evidence from a German cross‐sectional survey
Article in Birth Defects Research (June 2022)